Anula Kusum Jayasuriya

Director/Board Member chez JAGUAR HEALTH, INC. Fortune : 21 126 $ au 31/03/2024

Profil

Anula Kusum Jayasuriya is the founder of Evolvence India Life Sciences Fund (2006), EXXclaim Capital (2013), and Kidron Capital Assets LP (2022).
Dr. Jayasuriya is also the founder of Ocimum Bio Solutions (India) Ltd.
Dr. Jayasuriya's current job(s) include being an Independent Chairman at Aarvik Therapeutics, Inc., an Independent Director at Lineage Cell Therapeutics, Inc., a Director at Level Playing Field Corp., a Director-Outcomes Research at Syntex Laboratories, Inc., a Director at Ocimum Biosolutions, Inc., a Director at Gruter Institute for Law & Behavioral Research, a Director at Mapmygenome India Ltd., a Director at Jaguar Health, Inc., a Director at Solarea Bio, Inc., a Director at Watkins-Conti Products, Inc., a Trustee at Astia, Inc., an Investment Advisor at RH Capital LLC, and a Venture Partner at Digitaldx Ventures Management LLC.
Dr. Jayasuriya's former job(s) include being a Director at Lipomics Technologies, Inc., a Director at nVision Medical Corp., a Director at HealthCare Global Enterprises Ltd., a Director at Harvard Business School Health Industry Alumni Association, a Director at LuMind Research Down Syndrome Foundation, a Partner at TVM Capital GmbH, a Partner at Skyline Management LLC, a Partner at Skyline Ventures (California) (2001-2002), and a Vice President-Corporate Development at Genomics Collaborative, Inc. (1999-2000).
Dr. Jayasuriya's education history includes undergraduate studies at Harvard University, graduate studies at the University of Cambridge, a doctorate from Harvard Medical School, and an MBA from Harvard Business School.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
LINEAGE CELL THERAPEUTICS, INC. 0,01%	29/12/2023	10 000 ( 0,01% )	14 800 $	31/03/2024
JAGUAR HEALTH, INC. 0,03%	14/08/2023	70 286 ( 0,03% )	6 326 $	31/03/2024

Postes actifs de Anula Kusum Jayasuriya

Sociétés	Poste	Début
LINEAGE CELL THERAPEUTICS, INC.	Director/Board Member	04/05/2021
JAGUAR HEALTH, INC.	Director/Board Member	01/07/2022
Digitaldx Ventures Management LLC	Private Equity Investor	01/07/2022
RHIA Capital LLC	Consultant / Advisor	-
Solarea Bio, Inc.	Director/Board Member	-
Syntex Laboratories, Inc.	Corporate Officer/Principal	-
EXXclaim Capital	Chief Executive Officer	01/01/2013
Watkins-Conti Products, Inc.	Director/Board Member	-
Aarvik Therapeutics, Inc.	Chairman	-
░░░░░░░░░░░ ░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	-

Anciens postes connus de Anula Kusum Jayasuriya

Sociétés	Poste	Fin
░░░░░░░░░ ░░░░░ ░░░░ ░░░░░░░░ ░░░░	░░░░░░░	░░░░░░░░░░
░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░░ ░░░░░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░

Formation de Anula Kusum Jayasuriya

Harvard University	Undergraduate Degree
University of Cambridge	Graduate Degree
Harvard Medical School	Doctorate Degree
Harvard Business School	Masters Business Admin